Allianz Asset Management Gmb H Paratek Pharmaceuticals, Inc. Transaction History

Allianz Asset Management Gmb H

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$4.8 - $11.6 $351,537 - $849,549	-73,237 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$9.05 - $10.95 $52,607 - $63,652	5,813 Added 8.62%	73,237 $710,000
Q2 2018 Aug 13, 2018	BUY	$10.2 - $13.9 $41,748 - $56,892	4,093 Added 6.46%	67,424 $688,000
Q1 2018 May 14, 2018	SELL	$12.65 - $18.85 $15,395 - $22,940	-1,217 Reduced 1.89%	63,331 $823,000
Q4 2017 Feb 13, 2018	SELL	$17.45 - $25.6 $14,274 - $20,940	-818 Reduced 1.25%	64,548 $1.16 Million
Q3 2017 Nov 13, 2017	BUY	$18.9 - $28.2 $70,289 - $104,875	3,719 Added 6.03%	65,366 $1.64 Million
Q2 2017 Aug 14, 2017	BUY	N/A	13,628 Added 28.38%	61,647 $1.49 Million
Q1 2017 Apr 17, 2019	BUY	N/A	48,019	48,019 $924,000

1.54M

Ticker PRTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,862,500
Description
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

Stay updated on Allianz Asset Management Gmb H with notifications on news.